Cochrane Abstracts
Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals: Cochrane systematic review
Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals: Cochrane systematic review is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Tenofovir or Zidovudine in Three-drug Combination Therapy With One Nucleoside Reverse Transcriptase Inhibitor and One Non-nucleoside Reverse Transcriptase Inhibitor for Initial Treatment of HIV Infection in Antiretroviral-naïve Individuals: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432835/all/Oral_5���aminosalicylic_acid_for_induction_of_remission_in_ulcerative_colitis_New_search_for_studies_and_content_updated__no_change_to_conclusions_. Accessed 27 March 2023.
Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432835/all/Oral_5���aminosalicylic_acid_for_induction_of_remission_in_ulcerative_colitis_New_search_for_studies_and_content_updated__no_change_to_conclusions_. Accessed March 27, 2023.
Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432835/all/Oral_5���aminosalicylic_acid_for_induction_of_remission_in_ulcerative_colitis_New_search_for_studies_and_content_updated__no_change_to_conclusions_
Tenofovir or Zidovudine in Three-drug Combination Therapy With One Nucleoside Reverse Transcriptase Inhibitor and One Non-nucleoside Reverse Transcriptase Inhibitor for Initial Treatment of HIV Infection in Antiretroviral-naïve Individuals: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2023 March 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432835/all/Oral_5���aminosalicylic_acid_for_induction_of_remission_in_ulcerative_colitis_New_search_for_studies_and_content_updated__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals: Cochrane systematic review
ID - 432835
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432835/all/Oral_5���aminosalicylic_acid_for_induction_of_remission_in_ulcerative_colitis_New_search_for_studies_and_content_updated__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
